Neoadjuvant Cancer Immunotherapy Set For Takeoff, Fueled By Strong Data

Dreams of a future with early curative treatments drives wave of drug development in pre-surgical and perioperative treatment in many tumor types.

Neoadjuvant use of IO therapy is set for launch

More from Outlook

More from Innovation